ArticleHaemophilia : the official journal of the World Federation of Hemophilia2021

Development and testing of the Satisfaction Questionnaire with Intravenous or Subcutaneous Hemophilia Injection and results from the Phase 3 HAVEN 3 study of emicizumab prophylaxis in persons with haemophilia A without FVIII inhibitors.

Christine Kempton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.